← Back to Search

Electrohydraulic Device

Rapid Acoustic Pulse Therapy for Cellulite

Phase 4
Waitlist Available
Research Sponsored by Zeltiq Aesthetics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Must not have
Any surgical procedure in the treatment areas in the prior 3 months or planned during the duration of the study
Medical disorder that would hinder wound healing or immune response
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 72 weeks
Awards & highlights
Pivotal Trial
Drug Has Already Been Approved
No Placebo-Only Group

Summary

This trial is testing a device called RAP that uses sound waves to improve the look of cellulite. It targets adults aged 18-50 who want to reduce cellulite on their thighs and buttocks. The sound waves break up tiny fibers under the skin, making it look smoother. Ultrasound is efficacious for skin rejuvenation, body contouring, and reduction of cellulite.

Who is the study for?
Adults aged 18-50 with moderate to severe cellulite on thighs or buttocks can join this trial. They shouldn't have had any tanning treatments, invasive cellulite procedures, or used topical cellulite treatments for the past 3 months. Those with metal/plastic implants, electronic devices like pacemakers, blood clotting issues, skin disorders in the area, or recent surgeries are excluded.
What is being tested?
The Rapid Acoustic Pulse (RAP) device is being tested for its effectiveness in improving the appearance of cellulite on the thighs and buttocks. Participants will undergo three treatment sessions and be monitored over a period of up to 72 weeks through medical assessments and questionnaires.
What are the potential side effects?
Potential side effects may include discomfort at the treatment site, bruising, swelling, redness or changes in skin sensation. The study aims to assess these adverse events thoroughly during regular clinic visits.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I haven't had surgery in the treatment area in the last 3 months and don't plan to during the study.
Select...
I do not have any health conditions that could affect wound healing or my immune system.
Select...
I have a blood clotting disorder or am on blood thinners.
Select...
I have skin conditions like infections, rashes, or psoriasis in the areas to be treated.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~72 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 72 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Participants with Adverse Events
Percentage of Participants with Improvement in the Appearance of Cellulite as Determined by Blinded Independent Physician Reviewers (IPR)
Secondary study objectives
Percentage of Participants with "Agree" or "Strongly Agree" Responses to the Participant Satisfaction Survey in the Improvement in Appearance of Cellulite

Awards & Highlights

Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Rapid Acoustic Pulse (RAP)Experimental Treatment1 Intervention
Participants will receive 3 separate RAP cellulite treatments sessions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Rapid Acoustic Pulse
2023
Completed Phase 4
~80

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for cellulite, such as Rapid Acoustic Pulse (RAP), radiofrequency (RF), and ultrasound, work by targeting the structural issues beneath the skin. RAP uses electrohydraulic pulses to disrupt the connections between the skin and underlying tissue, reducing dimples and ridges. RF induces tissue contraction, and ultrasound enhances blood flow and promotes tissue regeneration. These mechanisms are important for cellulite patients as they address the root causes of cellulite, potentially improving skin texture and appearance.
Effects of ultrasound and trolamine salicylate phonophoresis on delayed-onset muscle soreness.Effect of different intensity pulsed ultrasound on the restoration of rat skeletal muscle contusion.Ultrasound modulates the inflammatory response and promotes muscle regeneration in injured muscles.

Find a Location

Who is running the clinical trial?

Zeltiq AestheticsLead Sponsor
40 Previous Clinical Trials
1,834 Total Patients Enrolled
3 Trials studying Cellulite
134 Patients Enrolled for Cellulite

Media Library

Rapid Acoustic Pulse (RAP) Device (Electrohydraulic Device) Clinical Trial Eligibility Overview. Trial Name: NCT05664581 — Phase 4
Cellulite Research Study Groups: Rapid Acoustic Pulse (RAP)
Cellulite Clinical Trial 2023: Rapid Acoustic Pulse (RAP) Device Highlights & Side Effects. Trial Name: NCT05664581 — Phase 4
Rapid Acoustic Pulse (RAP) Device (Electrohydraulic Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05664581 — Phase 4
Cellulite Patient Testimony for trial: Trial Name: NCT05664581 — Phase 4
~5 spots leftby Nov 2025